Cargando…
New Targets for Renal Interstitial Fibrosis: Relaxin Family Peptide Receptor 1 - Angiotensin Type 2 Receptor Heterodimers
Recent findings have shown that relaxin has potent anti-fibrotic effects within the kidney; however, the signal transduction mechanisms involved in the renoprotective effects of relaxin are not well understood. Chow et al demonstrate that the relaxin receptor, RXFP1, forms heterodimer complexes with...
Autor principal: | Sasser, Jennifer M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076695/ https://www.ncbi.nlm.nih.gov/pubmed/24978374 http://dx.doi.org/10.1038/ki.2014.22 |
Ejemplares similares
-
Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin
por: Bruell, Shoni, et al.
Publicado: (2017) -
New Insights into Ligand-Receptor Pairing and Coevolution of Relaxin Family Peptides and Their Receptors in Teleosts
por: Good, Sara, et al.
Publicado: (2012) -
Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants
por: Speck, David, et al.
Publicado: (2022) -
Relaxin abrogates renal interstitial fibrosis by regulating macrophage polarization via inhibition of Toll-like receptor 4 signaling
por: Chen, Lei, et al.
Publicado: (2017) -
Erratum to “New Insights into Ligand-Receptor Pairing and Coevolution of Relaxin Family Peptides and Their Receptors in Teleosts”
por: Good, Sara, et al.
Publicado: (2013)